The goal of this clinical trial is to learn if knowing risk for diabetes can help adult patients with prediabetes take steps to get care and prevent diabetes. The main questions it aims to answer are: * Does a shared-decision making visit with a health care team member to talk about the participant's diabetes risk increase participants' taking steps to prevent diabetes? * Does a simple message in the patient portal about the participant's diabetes risk increase participants' taking steps to prevent diabetes? Researchers will compare the visit with usual care at the clinic to see if the visit increases participants' taking steps to prevent diabetes. Separately, the researchers will compare the patient message with usual care at the clinic to see if the message increases participants' taking steps to prevent diabetes. Participants will: * Complete surveys at the beginning of the study and up to 2 additional surveys * If the participant falls into the shared decision-making group, the participant will have one 30-minute visit with a healthcare team member to talk about risk of diabetes and how to lower it.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
120
Single visit with health care team member to discuss diabetes risk and choosing next steps
Single message delivered via patient portal system describing diabetes risk and tips to lower risk
Johns Hopkins Community Physicians Frederick
Frederick, Maryland, United States
RECRUITINGPresence of a DPP referral or new metformin prescription
Prediabetes treatment uptake - Presence of a DPP referral or new metformin prescription based on electronic health record data
Time frame: From randomization to 3 months after randomization
Proportion of patients enrolled in the DPP
DPP enrollment- Proportion of patients enrolled in the DPP -
Time frame: Referral to 6 months after DPP referral
Proportion of patients who complete ≥ 9 months of the DPP
DPP completion- Proportion of patients who complete ≥ 9 months of the DPP
Time frame: From enrollment to 12 months of follow-up
Weight change (kg)
Change in body weight
Time frame: From enrollment to 12 months
Metformin adherence
Proportion of participants with a new metformin prescription who have a proportion-of-days covered (PDC) value of ≥0.80 (calculated as the sum of days' supply of metformin divided by the number of days between the first fill and end of follow-up period).
Time frame: From enrollment to 12 months
Hemoglobin A1c change
Absolute change in hemoglobin A1c
Time frame: From enrollment to 12 months
Patient Activation Measure
Patient Activation Measure (PAM) scored as Level 1(disengaged) - 4 (proactive)
Time frame: From enrollment to 3 months and from enrollment to 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.